These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3928265

  • 1. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM, Lamport PA, Reeves DS, Bywater MJ, Holt HA, Wise R, Andrews J, Hall MJ.
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
    Frimodt-Møller N, Højbjerg T, Hvass E, Møller S, Mortensen I, Thomsen VF.
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
    [Abstract] [Full Text] [Related]

  • 4. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 5. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
    Digranes A, Benonisen E, Dibb WL.
    Infection; 1982 Jun; 10(5):307-9. PubMed ID: 6293978
    [Abstract] [Full Text] [Related]

  • 6. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [Abstract] [Full Text] [Related]

  • 7. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I, Machka K, Elsser R.
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of HR 810, a new broad-spectrum cephalosporin.
    Machka K, Braveny I.
    Eur J Clin Microbiol; 1983 Aug; 2(4):345-9. PubMed ID: 6313358
    [Abstract] [Full Text] [Related]

  • 9. Antibacterial properties of Ro 13-99041, a long-acting new cephalosporin.
    Angehrn P, Probst PJ.
    Chemotherapy; 1981 Aug; 27 Suppl 1():9-14. PubMed ID: 7249797
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A, Major P.
    Microb Drug Resist; 1996 Aug; 2(3):361-9. PubMed ID: 9158796
    [Abstract] [Full Text] [Related]

  • 11. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN, Barry AL, Thornsberry C.
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [Abstract] [Full Text] [Related]

  • 12. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
    Baumgartner JD, Glauser MP.
    Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
    [Abstract] [Full Text] [Related]

  • 14. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I, Warren C, Shannon K, King A, Hanslo D.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
    Hoogkamp-Korstanje JA, Meijer CA.
    Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
    [Abstract] [Full Text] [Related]

  • 16. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA, Day GJ, Humble MW.
    N Z Med J; 1982 Jun 23; 95(710):414-6. PubMed ID: 6810246
    [Abstract] [Full Text] [Related]

  • 17. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
    Hart CA, Percival A.
    J Antimicrob Chemother; 1983 Jan 23; 11 Suppl():95-101. PubMed ID: 6573329
    [Abstract] [Full Text] [Related]

  • 18. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
    Machka K, Dietz R.
    Eur J Clin Microbiol; 1983 Oct 23; 2(5):496-500. PubMed ID: 6315425
    [Abstract] [Full Text] [Related]

  • 19. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E, Limbert M, Seeger K, Seibert G, Novick WJ.
    Diagn Microbiol Infect Dis; 1984 Jun 23; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [Abstract] [Full Text] [Related]

  • 20. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A.
    J Antimicrob Chemother; 1985 Jun 23; 15 Suppl C():155-64. PubMed ID: 3897170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.